At a glance
ClinicalIndex Comparison RecordN/ACompleted· 35 enrolled
Drug / intervention
Optive® Fusion + Optive® Gel Dropdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Optive Brand For Day And Night Dry Eye Management
In Brief
A clinical study evaluating Optive® Fusion + Optive® Gel Drop for Dry Eye. Completed, enrolled 35 participants across 1 site.
Detailed Summary
This is an open label study of Optive eyedrops and gel combination for day and night dry eye management
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDry Eye
CountriesUnited Kingdom
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartJul 2017
First PostedJul 2017
Primary CompletionSep 2017
TodayJul 2026
First PostedJul 5, 2017
Enrollment StartJul 3, 2017
Primary CompletionSep 6, 2017
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 9.0 years ago
Interventions
Optive® Fusion + Optive® Gel Dropdevice
Optive® Fusion eyedrop will be used as needed up to four times a day but at least twice a day. The eyedrop will be used once in the evening; the gel drop being instilled any time during the last hour prior to sleep.